SurgaColl’s Equine research recognised at Top Irish Bioengineering Conference

This weekend, SurgaColl’s Founder & CTO, Dr. John Gleeson, received the Royal Academy of Medicine in Ireland 3rd place award for his conference paper highlighting a successful Horse Jaw regeneration study using SurgaColl’s flagship product HydroxyColl. The study was carried out at the Troytown Greyabbey Equine Veterinary Surgery ( with Dr. Cormac Feeney and his […]

Peter Hamer joins SurgaColl as Chief Executive Officer

We are delighted to announce the appointment of Peter Hamer as Chief Executive Officer. Mr. Hamer succeeds Bill Allan as CEO following Bill’s decision to retire from full time executive roles. Peter has held multiple leadership positions in the MedTech/Medical Devices sector and has been responsible for product development, marketing and international sales & distribution […]

ISO13485:2016 Certification

SurgaColl Holdings is proud to announce that the company had a successful ISO13485:2016 transition audit and has been recommended for certification by BSI. This reflects the company’s commitment to the highest level of medical device quality.

SurgaColl Partners with Sparta to Deliver High-Quality Tissue Regeneration Products, Improve Accessibility and Time-to-Market

Sparta Systems, Inc., the leading provider of quality and regulatory affairs management software is partnering with SurgaColl™ Technologies. SurgaColl has chosen Sparta’s cloud QMS platform, TrackWise Digital, to replace its paper-based quality management system, allowing it to better focus on product quality, market-place accessibility, and bringing products to market more quickly. According to John Hoare, […]

Greg Stirling joins the team

We are very pleased to announce that Greg Stirling will be joining the business as Finance and Admin Manager based in the Alderley Park Office in Cheshire. Greg has a very strong background in Operational Finance and his most recent role is Head of Finance at Venn Digital. He has a BA in Business Management […]

15th Anglonordic Life Science Conference

Dr Bill Allan, our CEO will be attending the 15th Anglonordic Life Science Conference on Thursday 24th May at County Hall in London. Anglonordic is the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other. The event […]

Knowledge Transfer Ireland (KTI) Impact Awards in Dublin – recognition for SurgaColl!

Six innovation projects from Ireland’s research and technology sectors won prizes at the annual Knowledge Transfer Ireland (KTI) Impact Awards in Dublin on Thursday. The Royal College of Surgeons Ireland was awarded the “Spin-out Company” award for SurgaColl. The awards were presented by John Halligan, the Minister of State for Training, Skills, Innovation, Research and […]

Stephen Cook joins the team

We are delighted to announce that Stephen Cook has joined the SurgaColl UK based team as Clinical Research Associate with effect March 2018. Stephen is an accomplished and experienced Clinical Research leader with 18 years of working experience, encompassing Medical Devices and Pharma. He has a very strong understanding and insight of processes in the […]

ICRS 2018 – 14th World Congress, Macau, China

Dr John Gleeson will be attending the ICRS (International Cartilage Repair Society) Congress in Macau, China from 9th to 12th April. Their mission is to advance science and education in the field of cartilage repair and regenerative medicine worldwide. Held for the first time in Asia, the ICRS 2018 will provide a networking opportunity for the […]

The MedTech Strategist, Dublin April 2018

Our CEO, Bill Allan will be attending The MedTech Strategist in Dublin 17-19 April. This exceptional investment and networking event is recognised by the medical device industry as the leading medical technology investment forum in Europe. Click here for further information about the event.